Premium
A long‐term study of labetalol in general practice.
Author(s) -
Kane J,
Gregg I,
Stephens MD
Publication year - 1979
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1979.tb04775.x
Subject(s) - labetalol , medicine , rash , myocardial infarction , anesthesia , cardiology , blood pressure
1 Forty‐one patients with mild to moderate hypertension have been treated with labetalol for up to 5 years. 2 Mean BP before treatment was 180/107 mm Hg, after 2–3 yr treatment was 136/81 mmHg and after 5 yr was 136/74 mmHg. 3 One patient developed a licheniform rash and two patients have died of myocardial infarction. No other side‐effects, not already observed in a previously reported double‐blind trial, have emerged.